Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionTownsquare Capital Llc
Latest Disclosed Ownership6,955 shares
Latest Disclosed Value $ 969,318
Townsquare Capital Llc reports 2.93% increase in ownership of GILD / Gilead Sciences, Inc.

On May 13, 2026 - Townsquare Capital Llc filed a 13F-HR form disclosing ownership of 6,955 shares of Gilead Sciences, Inc. (CH:GILD) valued at $969,318 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 6,757 shares of Gilead Sciences, Inc.. This represents a change in shares of 2.93% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F GILEAD SCIENCES COM 375558103 6,955 198 2.93 969 16.89 0.0922
2026-02-11 2025-12-31 13F GILEAD SCIENCES COM 375558103 6,757 -394 -5.51 829 4.54 0.1859
2026-02-11 2025-12-31 13F GILEAD SCIENCES COM 375558103 6,757 829
2026-02-11 2025-12-31 13F GILEAD SCIENCES COM 375558103 6,757 829
2026-02-11 2025-12-31 13F GILEAD SCIENCES COM 375558103 6,757 829
2026-02-11 2025-12-31 13F GILEAD SCIENCES COM 375558103 6,757 829
2026-02-11 2025-12-31 13F GILEAD SCIENCES COM 375558103 6,757 829
2025-11-03 2025-09-30 13F GILEAD SCIENCES COM 375558103 7,151 -5,145 -41.84 794 -41.82 0.1201
2025-08-13 2025-06-30 13F GILEAD SCIENCES COM 375558103 12,296 -122,357 -90.87 1,363 -90.97 0.1328
2025-05-12 2025-03-31 13F GILEAD SCIENCES COM 375558103 134,653 1,000 0.75 15,088 22.22 0.1607
2025-02-13 2024-12-31 13F GILEAD SCIENCES COM 375558103 133,653 -1,311 -0.97 12,345 9.10 0.1394
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 134,964 16,996 14.41 11,315 39.81 0.1355
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 117,968 723 0.62 8,094 -5.76 0.1104
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 117,245 -20,535 -14.90 8,588 -23.05 0.1258
2024-02-15 2023-12-31 13F GILEAD SCIENCES COM 375558103 137,780 62,052 81.94 11,162 96.67 0.1913
2023-11-15 2023-09-30 13F GILEAD SCIENCES COM 375558103 75,728 6,294 9.06 5,675 6.05 0.1036
2023-11-13 2023-06-30 13F GILEAD SCIENCES COM 375558103 69,434 5,228 8.14 5,351 0.45 0.0974
2023-05-11 2023-03-31 13F GILEAD SCIENCES COM 375558103 64,206 1,981 3.18 5,327 -0.28 0.1173
2023-02-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 62,225 -12,390 -16.61 5,342 16.03 0.1322
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 74,615 892 1.21 4,604 1.03 0.1318
2022-08-08 2022-06-30 13F GILEAD SCIENCES COM 375558103 73,723 32,173 77.43 4,557 84.49 0.1294
2022-04-28 2022-03-31 13F GILEAD SCIENCES COM 375558103 41,550 -23,367 -36.00 2,470 -47.60 0.0457
2022-04-28 2022-03-31 13F GILEAD SCIENCES COM 375558103 71,120 4,228
2022-02-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 64,917 -12,774 -16.44 4,714 -13.12 0.1182
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 77,691 7,440 10.59 5,426 12.90 0.1563
2021-08-16 2021-06-30 13F GILEAD SCIENCES COM 375558103 70,251 9,201 15.07 4,806 21.79 0.1554
2021-05-17 2021-03-31 13F GILEAD SCIENCES COM 375558103 61,050 14,824 32.07 3,946 46.53 0.1534
2021-02-16 2020-12-31 13F GILEAD SCIENCES COM 375558103 46,226 14,924 47.68 2,693 37.68 0.1198
2020-12-01 2020-09-30 13F/A-2 GILEAD SCIENCES COM 375558103 31,302 2,414 8.36 1,956 -11.69 0.1140
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 28,888 0 2,215 56,334.1308
2020-08-17 2020-06-30 13F GILEAD SCIENCES COM 375558103 28,888 25,617 783.15 2,215 745.42 0.1505
2020-05-18 2020-03-31 13F GILEAD SCIENCES COM 375558103 3,271 -353 -9.74 262 11.49 0.0212
2020-05-18 2019-12-31 13F GILEAD SCIENCES COM 375558103 3,624 -35 -0.96 235 0.43 0.0191
2019-11-14 2019-09-30 13F GILEAD SCIENCES COM 375558103 3,659 -281 -7.13 234 -8.59 0.0194
2019-08-15 2019-06-30 13F GILEAD SCIENCES COM 375558103 3,940 -11,775 -74.93 256 -74.95 0.0244
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM 375558103 15,715 12,039 327.50 1,022 310.44 0.0788
2019-02-12 2018-12-31 13F GILEAD SCIENCES COM 375558103 3,676 3,676 249 0.0324
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.